Income Statement Huangshan Novel Co.,Ltd

Equities

002014

CNE000001JZ2

Non-Paper Containers & Packaging

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
11.61 ^CNY	-0.26%		-1.53%	-2.60%

25-10-23	Huangshan Novel Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-09-19	Huangshan Novel Co.,Ltd Approves Interim Profit Distribution Plan for 2025, Payable on 30 September 2025	CI

769abb012192db927e0a050ae.uP4vjKyxsIQfYVlhWjiGrO8g9OzZIXRp8dOYgHnB6r4.gZtj5tSA3-NFJzxXFELAwKRlta-3TDsai7zC7TaCtfDeyhnl6sTbzWVXMg

Published financial data: HUANGSHAN NOVEL CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.66B	2.92B	3.21B	3.28B	3.41B
Other Revenues, Total	77.53M	106M	90.9M	102M	111M
Total Revenues	2.74B	3.02B	3.3B	3.38B	3.53B
Cost of Goods Sold, Total	2.08B	2.36B	2.59B	2.57B	2.71B
Gross Profit	653M	662M	715M	811M	817M
Selling General & Admin Expenses, Total	199M	199M	189M	186M	178M
Provision for Bad Debts	379K	-111K	2.67M	3.14M	3.81M
R&D Expenses	113M	121M	135M	145M	149M
Other Operating Expenses	17.53M	16.48M	22.02M	29.65M	-14.39M
Other Operating Expenses, Total	329M	337M	349M	364M	317M
Operating Income	323M	326M	366M	447M	500M
Interest Expense, Total	-6.35M	-8.21M	-13.2M	-18.45M	-12.15M
Interest And Investment Income	18.85M	20.82M	20.65M	34.99M	25.31M
Net Interest Expenses	12.5M	12.61M	7.45M	16.54M	13.15M
Currency Exchange Gains (Loss)	-3.03M	309K	3.15M	-10.32M	8.25M
Other Non Operating Income (Expenses)	-1.85M	-1.38M	-1.18M	-2.05M	-1.82M
EBT, Excl. Unusual Items	331M	337M	376M	451M	520M
Gain (Loss) On Sale Of Investments	1.33M	882K	478K	1.99M	7.1M
Gain (Loss) On Sale Of Assets	-119K	183K	13.63M	91.57K	-
Asset Writedown	-1.47M	-57.91K	-1.31M	-11.78M	-89.69K
Other Unusual Items	18.91M	21.81M	19.03M	19.29M	3.21M
EBT, Incl. Unusual Items	349M	360M	408M	461M	530M
Income Tax Expense	40.48M	38.8M	38.94M	46.76M	58.83M
Earnings From Continuing Operations	309M	321M	369M	414M	471M
Net Income to Company	309M	321M	369M	414M	471M
Minority Interest	-5.89M	-5.21M	-5.96M	-6.2M	-3.51M
Net Income - (IS)	303M	316M	363M	408M	468M
Net Income to Common Incl Extra Items	303M	316M	363M	408M	468M
Net Income to Common Excl. Extra Items	303M	316M	363M	408M	468M
Per Share Items
Net EPS - Basic	0.51	0.52	0.6	0.67	0.76
Basic EPS - Continuing Operations	0.51	0.52	0.6	0.67	0.76
Basic Weighted Average Shares Outstanding	596M	602M	605M	609M	615M
Net EPS - Diluted	0.49	0.52	0.6	0.67	0.76
Diluted EPS - Continuing Operations	0.49	0.52	0.6	0.67	0.76
Diluted Weighted Average Shares Outstanding	616M	611M	605M	609M	615M
Normalized Basic EPS	0.34	0.34	0.38	0.45	0.52
Normalized Diluted EPS	0.33	0.34	0.38	0.45	0.52
Dividend Per Share	0.42	0.42	0.4	0.55	0.62
Payout Ratio	67.31	81.69	73.07	64.1	74.34
Supplemental Items
EBITDA	433M	446M	492M	597M	652M
EBITA	325M	327M	368M	449M	502M
EBIT	323M	326M	366M	447M	500M
EBITDAR	434M	448M	494M	599M	654M
Total Revenues (As Reported)	2.74B	3.02B	3.3B	3.38B	3.53B
Effective Tax Rate - (Ratio)	11.58	10.78	9.55	10.14	11.1
Total Current Taxes	43.34M	36.85M	37.41M	50.89M	56.3M
Total Deferred Taxes	-2.86M	1.95M	1.53M	-4.13M	2.53M
Normalized Net Income	201M	205M	229M	276M	321M
Interest Capitalized	108K	-	-	-	-
Non-Cash Pension Expense	-	20.18K	-	10K	71.57K
Supplemental Operating Expense Items
Selling and Marketing Expenses	63.64M	54.81M	56.4M	57.58M	58.32M
General and Administrative Expenses	135M	144M	133M	129M	120M
Research And Development Expense From Footnotes	113M	121M	135M	145M	149M
Net Rental Expense, Total	1.61M	1.83M	1.96M	2M	2.01M
Imputed Operating Lease Interest Expense	735K	757K	649K	482K	234K
Imputed Operating Lease Depreciation	874K	1.07M	1.31M	1.52M	1.77M
Stock-Based Comp., G&A Exp. (Total)	27.29M	-	-	2.55M	-
Stock-Based Comp., Other (Total)	-	41.98M	13.4M	-	-
Total Stock-Based Compensation	27.29M	41.98M	13.4M	2.55M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	785M	787M	900M	1.18B	1.11B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	301M	30.88M	313M	302M	683M
Total Cash And Short Term Investments	1.09B	818M	1.21B	1.48B	1.79B
Accounts Receivable, Total	550M	667M	625M	698M	724M
Other Receivables	1.44M	647K	794K	1.13M	-
Notes Receivable	287K	89.04K	77.42K	189K	93.37K
Total Receivables	552M	668M	626M	700M	724M
Inventory	243M	333M	344M	303M	364M
Other Current Assets, Total	22.14M	25.12M	50.48M	25.86M	51.43M
Total Current Assets	1.9B	1.84B	2.23B	2.51B	2.93B
Gross Property Plant And Equipment	1.73B	1.96B	2.23B	2.3B	2.43B
Accumulated Depreciation	-824M	-940M	-1.02B	-1.13B	-1.28B
Net Property Plant And Equipment	906M	1.02B	1.2B	1.16B	1.15B
Long-term Investments	-	-	-	101M	104M
Other Intangibles, Total	79.18M	76.89M	83.27M	82.5M	80.66M
Deferred Tax Assets Long-Term	27.83M	27.29M	24.64M	27.8M	25.27M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	37.79M	42.16M	27.29M	21.27M	22.1M
Total Assets	2.95B	3.01B	3.57B	3.9B	4.31B
Liabilities
Accounts Payable, Total	440M	474M	489M	433M	493M
Accrued Expenses, Total	124M	132M	157M	167M	155M
Short-term Borrowings	195M	122M	466M	528M	793M
Current Portion of Long-Term Debt	-	-	4.8M	68.95M	30.1M
Current Income Taxes Payable	10.57M	4.11M	5.34M	8.32M	11.88M
Unearned Revenue Current, Total	13.1M	5.61M	7.75M	22.64M	13.4M
Other Current Liabilities	92.81M	56.89M	26.88M	16.2M	18.74M
Total Current Liabilities	875M	795M	1.16B	1.24B	1.51B
Long-Term Debt	-	-	45.67M	115M	130M
Unearned Revenue Non Current	47.81M	41.49M	45.79M	37.6M	33.81M
Deferred Tax Liability Non Current	399K	1.8M	-	-	-
Other Non Current Liabilities	-	-	-	1.75M	-
Total Liabilities	923M	838M	1.25B	1.4B	1.68B
Common Stock, Total	514M	514M	612M	612M	612M
Additional Paid In Capital	476M	518M	511M	513M	513M
Retained Earnings	1.1B	1.16B	1.17B	1.33B	1.46B
Treasury Stock	-103M	-67.9M	-14.31M	-	-
Comprehensive Income and Other	3.58M	3.1M	2.94M	2.49M	3.37M
Total Common Equity	1.99B	2.13B	2.28B	2.46B	2.59B
Minority Interest	40.36M	42.85M	46.09M	47.18M	47.29M
Total Equity	2.03B	2.17B	2.32B	2.5B	2.64B
Total Liabilities And Equity	2.95B	3.01B	3.57B	3.9B	4.31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	612M	612M	633M	612M	612M
ECS Total Common Shares Outstanding	612M	612M	633M	612M	612M
Book Value / Share	3.25	3.48	3.6	4.01	4.23
Tangible Book Value	1.91B	2.05B	2.2B	2.38B	2.51B
Tangible Book Value Per Share	3.12	3.35	3.47	3.88	4.1
Total Debt	195M	122M	516M	712M	953M
Net Debt	-892M	-696M	-696M	-768M	-842M
Debt Equivalent Oper. Leases	12.87M	14.61M	15.69M	16.04M	16.04M
Minority Interest, Total (Incl. Fin. Div)	40.36M	42.85M	46.09M	47.18M	47.29M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	86.5M	124M	128M	104M	117M
Inventories - Work In Process, Total	26.26M	35M	44.44M	44.54M	50.52M
Inventories - Finished Goods, Total	138M	184M	188M	175M	217M
Inventories - Others	8.79M	6.07M	3.36M	3.47M	3.67M
Buildings, Total	414M	483M	565M	648M	669M
Machinery, Total	1.26B	1.31B	1.41B	1.61B	1.74B
Full Time Employees	2.15K	2.13K	2.25K	2.28K	2.37K
Accumulated Allowance for Doubtful Accounts (Supple)	35.31M	33.76M	36.43M	39.61M	41.64M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	303M	316M	363M	408M	468M
Depreciation & Amortization - CF	108M	119M	124M	148M	150M
Amortization of Goodwill and Intangible Assets - (CF)	1.61M	1.83M	1.96M	2M	2.01M
Depreciation & Amortization, Total	109M	121M	126M	150M	152M
Amortization of Deferred Charges, Total - (CF)	485K	422K	398K	434K	544K
(Gain) Loss From Sale Of Asset	119K	-183K	-13.63M	-91.57K	-
(Gain) Loss on Sale of Investments - (CF)	-13.5M	-7.79M	-10.43M	-16.26M	-23.81M
Asset Writedown & Restructuring Costs	15.77M	10.23M	19.63M	33.89M	21.29M
Provision for Credit Losses	-103K	-	-	-	-
Provision and Write-off of Bad Debts	-	-	2.78M	3.38M	4.12M
Other Operating Activities, Total	8.44M	-6.78M	1.19M	6.72M	-1.94M
Change In Accounts Receivable	-601K	-116M	23.84M	-52.92M	-116M
Change In Inventories	9.15M	-99.77M	-29.28M	18.73M	-82.92M
Change In Accounts Payable	71.74M	35.84M	47.17M	-34.45M	58.63M
Change In Deferred Taxes	-2.86M	1.95M	1.53M	-4.13M	2.53M
Change in Other Net Operating Assets	47.59M	41.34M	11.55M	2.13M	-20.94M
Cash from Operations	549M	296M	544M	515M	461M
Capital Expenditure	-262M	-241M	-308M	-110M	-152M
Sale of Property, Plant, and Equipment	315K	459K	11.36M	142K	39.72K
Investment in Marketable and Equity Securities, Total	-50M	130M	-282M	162M	-336M
Other Investing Activities, Total	18.49M	12.38M	13.56M	50.02M	34.63M
Cash from Investing	-293M	-97.72M	-566M	103M	-453M
Short Term Debt Issued, Total	223M	171M	-	-	-
Long-Term Debt Issued, Total	-	-	596M	684M	901M
Total Debt Issued	223M	171M	596M	684M	901M
Short Term Debt Repaid, Total	-72.26M	-244M	-	-	-
Long-Term Debt Repaid, Total	-	-	-209M	-498M	-603M
Total Debt Repaid	-72.26M	-244M	-209M	-498M	-603M
Issuance of Common Stock	78.14M	-	-	-	-
Repurchase of Common Stock	-	-158K	-	-	-
Common Dividends Paid	-204M	-258M	-265M	-262M	-348M
Common & Preferred Stock Dividends Paid	-204M	-258M	-265M	-262M	-348M
Other Financing Activities, Total	-17.72M	-138M	-	461K	-23.4M
Cash from Financing	7M	-468M	122M	-75M	-73.3M
Foreign Exchange Rate Adjustments	302K	866K	3.75M	405K	657K
Net Change in Cash	263M	-269M	103M	543M	-64.42M
Supplemental Items
Cash Income Tax Paid (Refund)	141M	110M	120M	135M	143M
Levered Free Cash Flow	213M	-94.55M	70.12M	265M	238M
Unlevered Free Cash Flow	217M	-89.43M	78.37M	276M	245M
Change In Net Working Capital	-139M	215M	-17.91M	46.55M	67.41M
Net Debt Issued / Repaid	151M	-72.33M	387M	186M	298M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.34	6.82	6.96	7.48	7.61
Return on Total Capital	9.73	9	8.92	9.23	9.19
Return On Equity %	15.73	15.28	16.4	17.15	18.33
Return on Common Equity	15.75	15.34	16.46	17.23	18.54
Margin Analysis
Gross Profit Margin %	23.84	21.9	21.65	24.01	23.18
SG&A Margin	7.26	6.59	5.72	5.51	5.06
EBITDA Margin %	15.8	14.76	14.9	17.67	18.49
EBITA Margin %	11.86	10.83	11.15	13.3	14.25
EBIT Margin %	11.8	10.77	11.09	13.24	14.19
Income From Continuing Operations Margin %	11.28	10.62	11.16	12.26	13.37
Net Income Margin %	11.07	10.45	10.98	12.08	13.27
Net Avail. For Common Margin %	11.07	10.45	10.98	12.08	13.27
Normalized Net Income Margin	7.34	6.8	6.93	8.17	9.12
Levered Free Cash Flow Margin	7.77	-3.13	2.12	7.83	6.75
Unlevered Free Cash Flow Margin	7.92	-2.96	2.37	8.17	6.96
Asset Turnover
Asset Turnover	1	1.01	1	0.9	0.86
Fixed Assets Turnover	3.18	3.14	2.97	2.86	3.05
Receivables Turnover (Average Receivables)	4.81	4.79	4.97	4.95	4.8
Inventory Turnover (Average Inventory)	8.18	8.2	7.66	7.94	8.12
Short Term Liquidity
Current Ratio	2.18	2.32	1.93	2.02	1.94
Quick Ratio	1.87	1.87	1.59	1.75	1.66
Operating Cash Flow to Current Liabilities	0.63	0.37	0.47	0.41	0.3
Days Sales Outstanding (Average Receivables)	76.05	76.13	73.4	73.73	76.21
Days Outstanding Inventory (Average Inventory)	44.73	44.49	47.67	45.94	45.09
Average Days Payable Outstanding	75.61	68.05	67.6	66.54	61.13
Cash Conversion Cycle (Average Days)	45.16	52.57	53.47	53.13	60.17
Long Term Solvency
Total Debt/Equity	9.6	5.61	22.21	28.43	36.14
Total Debt / Total Capital	8.76	5.31	18.17	22.14	26.54
LT Debt/Equity	-	-	1.96	4.59	4.92
Long-Term Debt / Total Capital	-	-	1.61	3.58	3.61
Total Liabilities / Total Assets	31.24	27.85	34.93	35.83	38.89
EBIT / Interest Expense	50.85	39.68	27.77	24.24	41.17
EBITDA / Interest Expense	68.06	54.38	37.31	32.36	53.65
(EBITDA - Capex) / Interest Expense	26.9	25.06	13.95	26.41	41.14
Total Debt / EBITDA	0.45	0.27	1.05	1.19	1.46
Net Debt / EBITDA	-2.06	-1.56	-1.41	-1.29	-1.29
Total Debt / (EBITDA - Capex)	1.14	0.59	2.81	1.46	1.91
Net Debt / (EBITDA - Capex)	-5.21	-3.38	-3.78	-1.58	-1.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.3	10.45	9.27	2.26	4.34
Gross Profit, 1 Yr. Growth %	6.13	1.49	8	13.42	0.74
EBITDA, 1 Yr. Growth %	15.19	3.05	10.26	21.16	6.36
EBITA, 1 Yr. Growth %	15.99	0.66	12.4	21.8	7.98
EBIT, 1 Yr. Growth %	16.43	0.75	12.57	22.04	8.12
Earnings From Cont. Operations, 1 Yr. Growth %	12.59	3.95	14.84	12.32	13.77
Net Income, 1 Yr. Growth %	12.6	4.25	14.85	12.46	14.63
Normalized Net Income, 1 Yr. Growth %	15.07	2.32	11.43	20.51	12.54
Diluted EPS Before Extra, 1 Yr. Growth %	9.27	5.08	15.38	11.67	13.43
Accounts Receivable, 1 Yr. Growth %	-0.95	21.25	-6.24	11.68	3.62
Inventory, 1 Yr. Growth %	-8.8	36.86	3.29	-11.88	20.38
Net Property, Plant and Equip., 1 Yr. Growth %	11.03	12.53	18.1	-3.5	-1.24
Total Assets, 1 Yr. Growth %	16.06	1.86	18.71	9.26	10.53
Tangible Book Value, 1 Yr. Growth %	6.83	7.31	7	8.18	5.63
Common Equity, 1 Yr. Growth %	7.17	6.91	7.05	7.85	5.36
Cash From Operations, 1 Yr. Growth %	28.05	-46	83.49	-5.19	-10.46
Capital Expenditures, 1 Yr. Growth %	59.94	-8.02	28.19	-64.43	38.58
Levered Free Cash Flow, 1 Yr. Growth %	37.84	-144.43	-174.16	277.39	-13.26
Unlevered Free Cash Flow, 1 Yr. Growth %	37.31	-141.25	-187.63	252.38	-14.1
Dividend Per Share, 1 Yr. Growth %	25.02	0	-4.01	37.5	12.73
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.34	7.85	9.86	5.71	3.29
Gross Profit, 2 Yr. CAGR %	13.7	3.78	4.69	10.67	6.89
EBITDA, 2 Yr. CAGR %	15.61	9.01	6.65	15.63	15.02
EBITA, 2 Yr. CAGR %	17.28	8.13	6.44	17.07	16.7
EBIT, 2 Yr. CAGR %	17.43	8.31	6.5	17.21	16.84
Earnings From Cont. Operations, 2 Yr. CAGR %	15.75	8.18	9.26	13.58	13.04
Net Income, 2 Yr. CAGR %	15.97	8.35	9.42	13.65	13.54
Normalized Net Income, 2 Yr. CAGR %	15.65	8.5	6.78	15.88	18.48
Diluted EPS Before Extra, 2 Yr. CAGR %	14.51	7.16	10.47	13.51	12.55
Accounts Receivable, 2 Yr. CAGR %	-0.74	9.59	6.62	2.33	7.58
Inventory, 2 Yr. CAGR %	-10.82	11.72	18.9	-4.6	2.99
Net Property, Plant and Equip., 2 Yr. CAGR %	8.4	11.78	15.28	6.75	-2.38
Total Assets, 2 Yr. CAGR %	7.92	8.73	9.96	13.88	9.89
Tangible Book Value, 2 Yr. CAGR %	3.72	7.07	7.16	7.59	6.89
Common Equity, 2 Yr. CAGR %	4.07	7.04	6.98	7.45	6.6
Cash From Operations, 2 Yr. CAGR %	30.16	-16.85	-0.46	31.9	-7.86
Capital Expenditures, 2 Yr. CAGR %	29.76	21.29	8.58	-32.47	-29.79
Levered Free Cash Flow, 2 Yr. CAGR %	45.37	-21.74	-42.6	67.29	84.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	45.58	-24.74	-39.87	75.73	77
Dividend Per Share, 2 Yr. CAGR %	19.52	11.81	-2.02	14.89	24.5
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.88	9.04	8.32	7.27	5.25
Gross Profit, 3 Yr. CAGR %	13.24	9.48	5.17	7.52	7.26
EBITDA, 3 Yr. CAGR %	11.23	11.31	9.46	11.31	13.44
EBITA, 3 Yr. CAGR %	12.83	11.51	9.58	11.37	15.29
EBIT, 3 Yr. CAGR %	12.92	11.58	9.71	11.44	15.4
Earnings From Cont. Operations, 3 Yr. CAGR %	13.5	11.67	10.36	10.27	13.64
Net Income, 3 Yr. CAGR %	13.82	11.92	10.47	10.43	13.98
Normalized Net Income, 3 Yr. CAGR %	13.1	11.02	9.47	11.17	16.08
Diluted EPS Before Extra, 3 Yr. CAGR %	12.9	11.28	10.06	10.86	13.48
Accounts Receivable, 3 Yr. CAGR %	0.41	6.11	4.04	8.28	2.76
Inventory, 3 Yr. CAGR %	-8.05	2.87	8.84	7.6	3.09
Net Property, Plant and Equip., 3 Yr. CAGR %	8.98	9.76	13.85	8.64	4.02
Total Assets, 3 Yr. CAGR %	7.16	5.86	11.96	9.73	12.76
Tangible Book Value, 3 Yr. CAGR %	3.91	4.9	7.05	7.5	6.93
Common Equity, 3 Yr. CAGR %	4.11	5.01	7.04	7.27	6.75
Cash From Operations, 3 Yr. CAGR %	25.54	-2.93	8.26	-2.06	15.92
Capital Expenditures, 3 Yr. CAGR %	50.67	15.7	23.55	-25.15	-14.19
Levered Free Cash Flow, 3 Yr. CAGR %	11.73	-2.08	-23.13	7.54	36.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.24	-4.38	-20.82	8.4	40.02
Dividend Per Share, 3 Yr. CAGR %	18.57	12.62	6.27	9.69	14.16
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.17	9.69	10.47	7.7	6.28
Gross Profit, 5 Yr. CAGR %	10.1	8.76	9.74	9.95	5.85
EBITDA, 5 Yr. CAGR %	9.24	7.53	9.4	13.04	11.67
EBITA, 5 Yr. CAGR %	10.06	8.06	10.26	13.73	12.4
EBIT, 5 Yr. CAGR %	10.13	8.1	10.31	13.8	12.51
Earnings From Cont. Operations, 5 Yr. CAGR %	9.78	9.12	11.78	12.43	11.43
Net Income, 5 Yr. CAGR %	9.78	9.28	12.04	12.61	11.69
Normalized Net Income, 5 Yr. CAGR %	8.96	7.84	10.53	12.94	12.99
Diluted EPS Before Extra, 5 Yr. CAGR %	9.2	9.16	11.92	12.31	11.05
Accounts Receivable, 5 Yr. CAGR %	3.99	5.98	2.85	4.58	5.44
Inventory, 5 Yr. CAGR %	0.41	3.58	1.91	-0.19	6.46
Net Property, Plant and Equip., 5 Yr. CAGR %	4.09	6.5	11.46	8.55	7.06
Total Assets, 5 Yr. CAGR %	6.58	5.74	8.27	9	11.13
Tangible Book Value, 5 Yr. CAGR %	3.74	4.27	5.2	5.97	6.99
Common Equity, 5 Yr. CAGR %	3.78	4.27	5.25	5.98	6.86
Cash From Operations, 5 Yr. CAGR %	16.34	1.09	14.41	9.74	1.5
Capital Expenditures, 5 Yr. CAGR %	9.74	18.87	32.16	-6.72	-1.45
Levered Free Cash Flow, 5 Yr. CAGR %	132.42	1.3	-14.4	21.32	9.03
Unlevered Free Cash Flow, 5 Yr. CAGR %	127.75	-0.02	-12.56	21.97	9.23
Dividend Per Share, 5 Yr. CAGR %	13.4	8.45	9.86	13.52	13.22